LRRK2 and Parkinson disease: In patients with LRRK2 mutations and clinically manifest PD, the associated neuropathology is heterogeneous ranging from LB pathology with a variable burden of Tau neurofibrillary tangles (NFTs) to Tau-only pathology and no inclusions [10], [35], [36], [37], [38].